Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
Language English Country United States Media print
Document type Journal Article, Practice Guideline
Grant support
9609
Cancer Research UK - United Kingdom
PubMed
38295337
DOI
10.1182/blood.2023020794
PII: S0006-4971(24)00307-0
Knihovny.cz E-resources
- MeSH
- Precursor Cell Lymphoblastic Leukemia-Lymphoma * diagnosis therapy MeSH
- Adult MeSH
- Humans MeSH
- Prognosis MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Practice Guideline MeSH
- Geographicals
- Europe MeSH
Working groups of the European LeukemiaNet have published several important consensus guidelines. Acute lymphoblastic leukemia (ALL) has many different clinical and biological subgroups and the knowledge on disease biology and therapeutic options is increasing exponentially. The European Working Group for Adult ALL has therefore summarized the current state of the art and provided comprehensive consensus recommendations for diagnostic approaches, biologic and clinical characterization, prognostic factors, and risk stratification as well as definitions of endpoints and outcomes. Aspects of treatment, management of subgroups and specific situations, aftercare, and supportive care are covered in a separate publication. The present recommendation intends to provide guidance for the initial management of adult patients with ALL and to define principles as a basis for future collaborative research.
Department of Internal Medicine Hematology and Oncology University Hospital Brno Brno Czech Republic
Department of Medicine 2 Hematology Oncology Goethe University University Hospital Frankfurt Germany
Division of Cancer and Genetics Cardiff University School of Medicine Cardiff United Kingdom
Division of Hematology Ospedale dell'Angelo Mestre Venice Italy
Erasmus MC Cancer Institute Rotterdam The Netherlands
Hematology Department of Translational and Precision Medicine Sapienza University Rome Italy
Hospital Saint Louis Assistance Publique Hôpitaux de Paris Paris France
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori Meldola Italy
UCL Cancer Institute London United Kingdom
University Hospitals Bristol NHS Foundation Trust Bristol United Kingdom
References provided by Crossref.org